Approvals/NMPA/Recombinant Human Coagulation Factor VIIa for Injection（Eptacog alfa, activated)

Approved

生物制品

Recombinant Human Coagulation Factor VIIa for Injection（Eptacog alfa, activated)

Novo Nordisk A/S🇨🇳 National Medical Products Administration

Approval Id: 7MazXbITYy3
Approval Number: S20150062
Generic Name: 注射用重组人凝血因子Ⅶa
Generic Name En: Recombinant Human Coagulation Factor VIIa for Injection（Eptacog alfa, activated)
Trade Name: 诺其
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 2mg(100KIU)/支
Reg Date: 2020-01-14
Expired Date: 2025-01-13
Company Name: Novo Nordisk A/S
Company Address: Novo Alle,DK-2880 Bagsvaerd,Denmark
Production Company Name: Novo Nordisk A/S
Production Company Address: Novo Alle,DK-2880,Bagsvaerd,Denmark
Company Detail Path: /organization/novo-nordisk-a-s
Production Company Detail Path: /organization/novo-nordisk-a-s

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 14, 2020

Approval ID

7MazXbITYy3

Type

生物制品